SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950005-02-000830
Filing Date
2002-08-13
Accepted
2002-08-13 14:36:36
Documents
4
Period of Report
2002-06-30

Document Format Files

Seq Description Document Type Size
1 p15914_10q.txt 10-Q 49309
3 AMENDED AND RESTATED ARTICLES OF INCORPORATION p15914_ex3-1.txt EX-3.1(I) 3785
4 1995 EQUITY INCENTIVE PLAN p15914_ex10-7.txt EX-10.7 58641
5 1995 DIRECTORS STOCK OPTION PLAN p15914_ex10-8.txt EX-10.8 22605
  Complete submission text file 0000950005-02-000830.txt   136276
Mailing Address 349 OYSTER POINT BLVD. SUITE 200 SO. SAN FRANCISCO CA 94080
Business Address 349 OYSTER POINT BLVD. SUITE 200 SO. SAN FRANCISCO CA 94080 6506262200
CELLEGY PHARMACEUTICALS INC (Filer) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26372 | Film No.: 02729203
SIC: 2834 Pharmaceutical Preparations